Related Experiment Videos

Intravenous aminophylline therapy for asthma. A comparison of two methods of administration in children

Insights

Continuous infusion of aminophylline in children with asthma significantly improved pulmonary function more than intermittent bolus doses. This asthma treatment comparison highlights optimal drug delivery for respiratory relief.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Pharmacology

Background:

  • Asthma is a common chronic respiratory disease in children.
  • Aminophylline is a bronchodilator used in asthma management.
  • Optimal administration methods for aminophylline in pediatric asthma require further investigation.

Purpose of the Study:

  • To compare the efficacy of continuous intravenous aminophylline infusion versus intermittent bolus administration in asthmatic children.
  • To evaluate the impact of different aminophylline dosing regimens on pulmonary function.

Main Methods:

  • Eleven pediatric patients with asthma participated in the study.
  • Two administration methods were tested: a loading dose followed by continuous infusion (6 mg/kg loading, 1.4 mg/kg/hr infusion) and intermittent bolus doses (4 mg/kg every 4 hours).
  • Expiratory flow rates, including forced expiratory volume at 1 second (FEV1) and expiratory flow at 50% of vital capacity (V50), were measured over 24 hours for each method.

Main Results:

  • Both continuous infusion and intermittent administration of aminophylline led to significant improvements in expiratory flow rates.
  • Continuous intravenous aminophylline infusion resulted in a significantly greater pulmonary response compared to intermittent bolus administration.
  • Improvements in FEV1 and V50 were more pronounced with the continuous infusion method.

Conclusions:

  • Continuous intravenous infusion of aminophylline is a more effective method for improving pulmonary function in children with asthma compared to intermittent bolus dosing.
  • This study suggests that optimizing aminophylline delivery can enhance bronchodilator therapy for pediatric asthma patients.

Related Concept Videos